Clinical Research Directory
Browse clinical research sites, groups, and studies.
Developing an Opioid Taper Intervention Before Total Joint Arthroplasty
Sponsor: University of Alabama at Birmingham
Summary
The goal of this clinical trial is to develop an pharmacist-led preoperative opioid taper intervention for patients undergoing total knee or hip replacement who are on chronic opioids before their surgery. The main questions it aims to answer are: * Is the intervention feasible and acceptable to patients? * Does the intervention result in a decrease in opioid dose during the preoperative period? Participants will meet with a clinical pharmacist, who will provide some basic education on pain and opioids, and will propose an opioid taper schedule. The pharmacist will then follow-up with the participant by phone each week until surgery to assess progress and adjust the taper as necessary.
Official title: Developing and Testing an Opioid Taper Intervention Before Total Knee Arthroplasty: Phase 2 Intervention Development
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
45
Start Date
2024-01-10
Completion Date
2026-09-01
Last Updated
2025-05-29
Healthy Volunteers
No
Conditions
Interventions
opioid taper
The participant will attempt to taper their opioid dose by \~50% during the 4-6 week preoperative period
Locations (1)
UAB Hospital-Highlands
Birmingham, Alabama, United States